The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of cancer"
DOI: 10.1002/ijc.34044
Abstract: Adjuvant chemotherapy has become standard of care for pancreatic ductal adenocarcinoma (PDAC) as it improves patient outcome. However, its clinical meaning in early-stage, UICC I tumors remains uncertain. We examined the effect of adjuvant therapy… read more here.
Keywords: outcome; stage; adjuvant therapy; impact adjuvant ... See more keywords
Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Strahlentherapie und Onkologie"
DOI: 10.1007/s00066-017-1225-7
Abstract: BackgroundTo date, it remains unclear whether locally advanced adenocarcinoma of the gastroesophageal junction (AEG) should be treated with neoadjuvant chemoradiation (nCRT), analogous to esophageal cancer, or with perioperative chemotherapy (pCT), analogous to gastric cancer. The… read more here.
Keywords: pct; uicc stage; patienten mit; der ... See more keywords